{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:05:26Z","timestamp":1784948726207,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030909","name":"Sawai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030909","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.xphs.2025.104007","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:41:37Z","timestamp":1758735697000},"page":"104007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Monitoring the concentration of nitrogen oxides in the fluidized bed drying\/granulation process and evaluation of reduction methods"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3202-3066","authenticated-orcid":false,"given":"Satoshi","family":"Kodama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9448-1074","authenticated-orcid":false,"given":"Kazuya","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1277-6416","authenticated-orcid":false,"given":"Saki","family":"Minamioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8875-3755","authenticated-orcid":false,"given":"Shun","family":"Matsuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3918-7824","authenticated-orcid":false,"given":"Naoki","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3160-3220","authenticated-orcid":false,"given":"Hiroyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Nagato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.104007_bib0002","article-title":"Nitrosamine contamination of pharmaceuticals: cases in Japan, formation mechanisms, detection methods, regulatory perspectives, and insights","volume":"4","author":"Tsuji","year":"2024","journal-title":"J Pharm Biomed Anal Open"},{"key":"10.1016\/j.xphs.2025.104007_bib0003","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jpba.2018.11.010","article-title":"NDMA impurity in valsartan and other pharmaceutical products: analytical methods for the determination of N-nitrosamines","volume":"164","author":"Parr","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2025.104007_bib0004","author":"Biba"},{"issue":"10","key":"10.1016\/j.xphs.2025.104007_bib0005","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/acs.oprd.3c00153","article-title":"Formation of N-nitrosamine drug substance related impurities in medicines: a regulatory perspective on risk factors and mitigation strategies","volume":"27","author":"Cioc","year":"2023","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2025.104007_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121687","article-title":"Nitrocellulose blister material as a source of N-nitrosamine contamination of pharmaceutical drug products","volume":"618","author":"Golob","year":"2022","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2025.104007_bib0007","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1021\/acs.oprd.5c00097","article-title":"Drug substance and drug product workflows for quality risk management for the presence of nitrosamines in medicines","volume":"29","author":"Dirat","year":"2025","journal-title":"Org Process Res Dev"},{"issue":"1","key":"10.1016\/j.xphs.2025.104007_bib0008","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0169-409X(01)00102-8","article-title":"Chemical reactivity in solid-state pharmaceuticals: formulation implications","volume":"48","author":"Byrn","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.xphs.2025.104007_bib0009","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1208\/s12249-011-9677-z","article-title":"Reactive impurities in excipients: profiling, identification and mitigation of drug\u2013excipient incompatibility","volume":"12","author":"Wu","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"10.1016\/j.xphs.2025.104007_bib0010","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/acs.oprd.2c00402","article-title":"Quantitation of reactive nitrosating agents in pharmaceutical excipients for N-nitrosamine risk assessments","volume":"27","author":"Yamamoto","year":"2023","journal-title":"Org Process Res Dev"},{"issue":"5","key":"10.1016\/j.xphs.2025.104007_bib0011","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.xphs.2023.03.007","article-title":"NDMA formation due to active ingredient degradation and nitrite traces in drug product","volume":"112","author":"Golob","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104007_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121740","article-title":"Avoiding N-nitrosodimethylamine formation in metformin pharmaceuticals by limiting dimethylamine and nitrite","volume":"620","author":"Schlingemann","year":"2022","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2025.104007_bib0013","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.xphs.2022.04.016","article-title":"A nitrite excipient database: a useful tool to support N-nitrosamine risk assessments for drug products","volume":"112","author":"Boetzel","year":"2023","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2025.104007_bib0014","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3390\/pharmaceutics15082015","article-title":"Modeling the impact of excipients selection on nitrosamine formation towards risk mitigation","volume":"15","author":"Berardi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.104007_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115648","article-title":"Parts per billion of nitrite in microcrystalline cellulose by ion chromatography mass spectrometry with isotope labeled internal standard","volume":"235","author":"Zhu","year":"2023","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2025.104007_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116330","article-title":"Highly sensitive two-dimensional ion chromatography mass spectrometry method for nitrite determination in hydroxypropyl methylcellulose","volume":"248","author":"Zhu","year":"2024","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"10.1016\/j.xphs.2025.104007_bib0017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1749-6632.1982.tb31232.x","article-title":"Efficacy of vitamin E to prevent nitrosamine formation","volume":"393","author":"Mergens","year":"1982","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.xphs.2025.104007_bib0018","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.xphs.2021.08.010","article-title":"Inhibition of N-nitrosamine formation in drug products: a model study","volume":"110","author":"Nanda","year":"2021","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2025.104007_bib0019","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.xphs.2023.03.022","article-title":"N-nitrosamine mitigation with nitrite scavengers in oral pharmaceutical drug product","volume":"112","author":"Bayne","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104007_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125806","article-title":"Impact of antioxidant addition on drug dissolution: implications for NDSRI mitigation biowaivers","volume":"681","author":"Valapil","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.104007_bib0021","first-page":"279","article-title":"Effects of some inhibitors on the nitrosation of drugs in human gastric juice","volume":"14","author":"Ziebarth","year":"1976","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.xphs.2025.104007_bib0022","series-title":"European Medicines Agency (EMA)","article-title":"Lessons learnt from presence of N-nitrosamine impurities in sartan medicines","year":"2020"},{"issue":"8","key":"10.1016\/j.xphs.2025.104007_bib0023","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1021\/acs.oprd.0c00264","article-title":"Controlling a cohort: use of mirabilis-based purge calculations to understand nitrosamine-related risk and control strategy options","volume":"24","author":"Burns","year":"2020","journal-title":"Org Process Res Dev"},{"issue":"2","key":"10.1016\/j.xphs.2025.104007_bib0024","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/acs.oprd.3c00487","article-title":"Risk assessment study of nitrosamines for the API temozolomide industrial process","volume":"28","author":"Secatto","year":"2024","journal-title":"Org Process Res Dev"},{"issue":"5","key":"10.1016\/j.xphs.2025.104007_bib0025","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1021\/acs.oprd.4c00540","article-title":"Development of an innovative three-component optical resolution and a flow chemistry process for (R)-troloxamide quinone (EPI-589)","volume":"29","author":"Usutani","year":"2025","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2025.104007_bib0026","series-title":"Food and Drug Administration","article-title":"U.S. Department of Health and Human Services","year":"2024"},{"key":"10.1016\/j.xphs.2025.104007_bib0028","series-title":"TRS 1060 - Annex 2: WHO Good Practice Considerations For the Prevention and Control of Nitrosamines in Pharmaceutical Products","year":"2025"},{"issue":"5","key":"10.1016\/j.xphs.2025.104007_bib0029","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.xphs.2023.01.027","article-title":"N-nitrosamine formation in pharmaceutical solid drug products: experimental observations","volume":"112","author":"Moser","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104007_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124832","article-title":"Nitrosamine mitigation: NDMA impurity formation and its inhibition in metformin hydrochloride tablets","volume":"666","author":"Shakleya","year":"2024","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2025.104007_bib0031","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1021\/acs.oprd.3c00274","article-title":"N-Nitrosodimethylamine Formation in Metformin Drug Products by the Reaction of Dimethylamine and Atmospheric NO2","volume":"27","author":"Fukuda","year":"2023","journal-title":"Org Process Res Dev"},{"issue":"20","key":"10.1016\/j.xphs.2025.104007_bib0032","article-title":"Technologies for the nitrogen oxides reduction from flue gas: a review","volume":"714","author":"Gholami","year":"2020","journal-title":"Sci Total Env"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.104007_bib0033","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.applthermaleng.2014.02.021","article-title":"Review of state of the art technologies of selective catalytic reduction of NOX from diesel engine exhaust","volume":"66","author":"Guan","year":"2014","journal-title":"Appl Therm Eng"},{"key":"10.1016\/j.xphs.2025.104007_bib0034","series-title":"E3S Web Conf.","article-title":"Simplified method for calculating SNCR system efficiency","volume":"14","author":"Pronobis","year":"2017"},{"issue":"1","key":"10.1016\/j.xphs.2025.104007_bib0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1001-0742(08)60004-2","article-title":"Study on the removal of NOX from simulated flue gas using acidic NaClO2 solution","volume":"20","author":"Deshwal","year":"2008","journal-title":"J Env Sci (Beijing China)"},{"issue":"8\u20139","key":"10.1016\/j.xphs.2025.104007_bib0036","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.fuel.2007.09.005","article-title":"Electron beam flue gas treatment (EBFGT) technology for simultaneous removal of SO2 and NOX from combustion of liquid fuels","volume":"87","author":"Basfar","year":"2008","journal-title":"Fuel"},{"issue":"8","key":"10.1016\/j.xphs.2025.104007_bib0037","doi-asserted-by":"crossref","first-page":"B1050","DOI":"10.1149\/1.3604778","article-title":"Tubular solid oxide electrolysis cell for NOX decomposition","volume":"158","author":"Hamamoto","year":"2011","journal-title":"J Electrochem Soc"},{"issue":"9","key":"10.1016\/j.xphs.2025.104007_bib0038","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1021\/acs.energyfuels.5b01286","article-title":"SOX\/NOX removal from flue gas streams by solid adsorbents: a review of current challenges and future directions","volume":"29","author":"Rezaei","year":"2015","journal-title":"Energy Fuels"},{"issue":"8","key":"10.1016\/j.xphs.2025.104007_bib0039","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0008-6223(96)00050-4","article-title":"NOX adsorption on char in presence of oxygen and moisture","volume":"34","author":"Kong","year":"1996","journal-title":"Carbon"},{"issue":"9","key":"10.1016\/j.xphs.2025.104007_bib0040","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0008-6223(97)00089-4","article-title":"Uptake of NOX by activated carbons: bench-scale and pilot-plant testing","volume":"35","author":"Neathery","year":"1997","journal-title":"Carbon"},{"key":"10.1016\/j.xphs.2025.104007_bib0041","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0008-6223(02)00190-2","article-title":"Mechanistic study on adsorption and reduction of NO2 over activated carbon fibers","volume":"40","author":"Shirahama","year":"2002","journal-title":"Carbon"},{"issue":"11","key":"10.1016\/j.xphs.2025.104007_bib0042","doi-asserted-by":"crossref","first-page":"205","DOI":"10.22161\/ijaers.5.11.29","article-title":"Adsorption of nitrogen dioxide (NO2) for different gas concentrations, temperatures and relative humidities by using activated carbon filter: an experimental study","volume":"5","author":"G\u00f6rg\u00fcl\u00fc","year":"2018","journal-title":"Int J Adv Eng Res Sci"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.104007_bib0043","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.apcatb.2006.09.016","article-title":"A comparison of NOX adsorption on Na, H and BaZSM-5 films","volume":"72","author":"Perdana","year":"2007","journal-title":"Appl Catal B"},{"key":"10.1016\/j.xphs.2025.104007_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.micromeso.2023.112746","article-title":"Exploring the framework of small pore zeolites for passive NOx adsorption","volume":"361","author":"Amen","year":"2023","journal-title":"Microporous Mesoporous Mater"},{"key":"10.1016\/j.xphs.2025.104007_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.fuel.2025.134611","article-title":"A numerical study of NOX removal from exhaust gas at low-temperature using metal Zeolite catalysts","volume":"391","author":"Cheng","year":"2025","journal-title":"Fuel"},{"issue":"3","key":"10.1016\/j.xphs.2025.104007_bib0046","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.envint.2004.09.006","article-title":"Pollution by nitrogen oxides: an approach to NOX abatement by using sorbing catalytic materials","volume":"31","author":"G\u00f3mez-Garc\u00eda","year":"2005","journal-title":"Env Int"},{"issue":"13","key":"10.1016\/j.xphs.2025.104007_bib0047","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202105484","article-title":"Metal\u2013organic frameworks for NOX adsorption and their applications in separation, sensing, catalysis, and biology","volume":"18","author":"Lin","year":"2022","journal-title":"Small"},{"issue":"23","key":"10.1016\/j.xphs.2025.104007_bib0048","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1021\/la4008137","article-title":"Effects of Carbon phase deposition in silica gel pores on NO2 reactive adsorption at ambient conditions on carbon\/silica composites","volume":"29","author":"Ebrahim","year":"2013","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.xphs.2025.104007_bib0049","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/j.2050-0416.1986.tb04373.x","article-title":"The chemistry of nitrosamine formation: relevance to malting and brewing","volume":"92","author":"Wainright","year":"1986","journal-title":"J Inst Brew"},{"key":"10.1016\/j.xphs.2025.104007_bib0050","first-page":"2123","article-title":"Exploration for chemical filter cartridges that can reduce nitrogen oxides, a common factor in the formation of nitrosamines","volume":"27","author":"Nomura","year":"2024","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2025.104007_bib0051","series-title":"Food and Drug Administration","article-title":"U.S. Department of Health and Human Services","year":"2023"},{"issue":"5","key":"10.1016\/j.xphs.2025.104007_bib0052","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.xphs.2023.01.021","article-title":"Nitrosated active pharmaceutical ingredients \u2013 lessons learned?","volume":"112","author":"Holzgrabe","year":"2023","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2025.104007_bib0053","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1021\/acs.oprd.3c00100","article-title":"The Nitrosamine \u201cSaga\u201d: lessons learned from five years of scrutiny","volume":"27","author":"Nudelman","year":"2023","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2025.104007_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105704","article-title":"N-Nitrosamine drug substance related impurities (NDSRIs) \u2013 A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight >200 Da","volume":"154","author":"Bercu","year":"2024","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.xphs.2025.104007_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105762","article-title":"Control of N-nitrosamine impurities in drug products: progressing the current CPCA framework and supporting the derivation of robust compound specific acceptable intakes","volume":"156","author":"Ponting","year":"2025","journal-title":"Regul Toxicol Pharmacol"},{"issue":"12","key":"10.1016\/j.xphs.2025.104007_bib0056","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.xphs.2023.10.001","article-title":"Revisiting the landscape of potential small and drug substance related nitrosamines in pharmaceuticals","volume":"112","author":"Burns","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104007_bib0057","series-title":"Food and Drug Administration, Center for Drug Evaluation and Research","article-title":"Recommended acceptable intake limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs) guidance for industry, Table 2: FDA recommended AI limits for certain nitrosamine impurities","author":"Nitrosamine Impurity Acceptable Intake Limits","year":"2025"},{"key":"10.1016\/j.xphs.2025.104007_bib0058","article-title":"Appendix 1: acceptable intakes established for N-nitrosamines","year":"2025","journal-title":"Eur Med Agency (EMA)"},{"key":"10.1016\/j.xphs.2025.104007_bib0059","series-title":"Pharmaceuticals and Medical Devices Agency (PMDA)","article-title":"Countermeasures against the risk of nitrosamine contamination in pharmaceuticals, List of nitrosamines to be referred to based on the notification (in Japanese)","year":"2025"},{"key":"10.1016\/j.xphs.2025.104007_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.powtec.2025.121297","article-title":"Consistent dry process for preparing functional particles with novel coating using two-step melt granulation","volume":"465","author":"Yoshihara","year":"2025","journal-title":"Powder Technol"},{"issue":"16\u201317","key":"10.1016\/j.xphs.2025.104007_bib0061","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/S0167-577X(02)01224-7","article-title":"Novel chemical filter using PET film support","volume":"57","author":"Horiuchi","year":"2003","journal-title":"Mater Lett"},{"key":"10.1016\/j.xphs.2025.104007_bib0062","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1246\/nikkashi.1978.303","article-title":"Oxidation adsorption of nitrogen monoxide on activated carbon","volume":"2","author":"Urano","year":"1978","journal-title":"Nippon Kagaku Kaishi"},{"key":"10.1016\/j.xphs.2025.104007_bib0063","unstructured":"Monitoring by Control Technique \u2013 Activated Carbon Adsorber. United States Environmental Protection Agency (EPA). Monitoring By Control Technique - Activated Carbon Adsorber | US EPA (accessed August 7th, 2025)."},{"key":"10.1016\/j.xphs.2025.104007_bib0064","article-title":"Simultaneous removal of SO2 and NOX from flue gas by low-temperature adsorption over activated carbon","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.xphs.2025.104007_bib0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1248\/cpb.47.819","article-title":"Reaction of secondary and tertiary amines with nitric oxide in the presence of oxygen","volume":"47","author":"Itoh","year":"1999","journal-title":"Chem Pharm Bull"},{"issue":"9","key":"10.1016\/j.xphs.2025.104007_bib0066","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1021\/acs.oprd.0c00323","article-title":"Pathways for N-nitroso compound formation: secondary amines and beyond","volume":"24","author":"L\u00f3pez-Rodr\u00edguez","year":"2020","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2025.104007_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.atmosenv.2025.121337","article-title":"Characteristics of the atmospheric behavior of particulate Nitro(so) compounds in the urban atmosphere of Seoul during Spring 2019: role of the oxides of nitrogen to the formation of Nitro(so) compounds","volume":"358","author":"Choi","year":"2025","journal-title":"Atmos Env"},{"key":"10.1016\/j.xphs.2025.104007_bib0068","unstructured":"Nitrogen Oxides Emissions, United States Environmental Protection Agency (U.S. EPA). (https:\/\/cfpub.epa.gov\/roe\/indicator.cfm?i=15) (Accessed June 16th, 2025)."},{"key":"10.1016\/j.xphs.2025.104007_bib0069","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhazmat.2013.02.012","article-title":"Full scale demonstration of air-purifying pavement","volume":"254-255","author":"Ballari","year":"2013","journal-title":"J Hazard Mater"},{"issue":"6","key":"10.1016\/j.xphs.2025.104007_bib0070","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/jof11060454","article-title":"Plant functional traits and soil nutrients drive divergent symbiotic fungal strategies in three urban street tree species","volume":"11","author":"Xue","year":"2025","journal-title":"J Fungi"},{"issue":"3","key":"10.1016\/j.xphs.2025.104007_bib0071","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0939-6411(01)00199-0","article-title":"New trends in the production of pharmaceutical granules: batch versus continuous processing","volume":"52","author":"Leuenberger","year":"2001","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2025.104007_bib0072","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijpharm.2019.01.028","article-title":"A large-scale experimental comparison of batch and continuous technologies in pharmaceutical tablet manufacturing using ethenzamide","volume":"559","author":"Matsunami","year":"2019","journal-title":"Int J Pharm"},{"issue":"20","key":"10.1016\/j.xphs.2025.104007_bib0073","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.3390\/electronics12204325","article-title":"Machine learning for energy-efficient fluid bed dryer pharmaceutical machines","volume":"12","author":"Barriga","year":"2023","journal-title":"Electronics"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:29:23Z","timestamp":1766525363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925004617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0022354925004617"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104007","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring the concentration of nitrogen oxides in the fluidized bed drying\/granulation process and evaluation of reduction methods","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"104007"}}